Surveillance for AI in Human Bureau of Epidemiology Health - - PDF document

surveillance for ai in human
SMART_READER_LITE
LIVE PREVIEW

Surveillance for AI in Human Bureau of Epidemiology Health - - PDF document

Surveillance for AI in Human Bureau of Epidemiology Health services Ministry of Public Health Central Department of disease control: Bureau of epidemiology Department of Medical science: NIH Regional disease control office Regional 12


slide-1
SLIDE 1

Surveillance for AI in Human

Bureau of Epidemiology

slide-2
SLIDE 2

Health services

Health center District health office District hospital Provincial health office 76 offices Provincial hospital 76 Regional disease control office 12 offices Village University hospital Private hospital Ministry of Public Health Department of disease control: Bureau of epidemiology Department of Medical science: NIH District level Province level Regional Central

slide-3
SLIDE 3

Influenza Pneumonia

Diseases under notification

slide-4
SLIDE 4

Annual cases report 1996-2002

slide-5
SLIDE 5

AI Surveillance in Human

Doing and Learning

slide-6
SLIDE 6

Source: BOE, MOPH Confirmed case Suspect case Area of outbreak in poultry First round (Jan-Mar 2004) Second round (Aug-Oct 2004) Third round (Oct05-Nov05)

Four waves of epidemic

New reported 2 cases on 26 July, 5 Aug 2006 in Pichit, Uthai

slide-7
SLIDE 7

Number of AI cases by date of onset, 2004

1 2 3 4 5 6 7 8 9 10

1-3 Jan 10-12 Jan 19-21 Jan 28-30 Jan 6-8 Feb 15-17 Feb 24-26 Feb 4-6 Mar 29-31 Aug 7-9 Sept 16-18 Sept 25-27 Sept 4-6 Oct

Suspect (22) Confirm (17) Probable (1)

slide-8
SLIDE 8

Enhancing surveillance for AI

Confirm AI in poultry and human Determine extent of problem Commitment of higher policy Construct structure and system Orientate the involving parties: physician,

lab, epidemiologist, logistic, risk communicator, policy maker,

Training the teams

slide-9
SLIDE 9

up to 10 March 2004

Announcement of the first confirm 23 Jan 2004

Capacity of confirmation in time

slide-10
SLIDE 10

Number of cases notified by week, Jan-Aug 2005

Third wave of human epidemic August-September 2005

Maintenance the system Surge Capacity

slide-11
SLIDE 11

Protection of high-risk groups

Case management and infection control

Migratory birds

Infected poultry

Risk communication for the public

Man

Disease Surveillance

Country AI control strategies

surveillance

Prevent exposure

Outbreak control in poultry

Transparency in operation and information

slide-12
SLIDE 12
  • 1. New influenza

virus in animals low risk for human

  • 2. High risk

for human

  • 3. Human infections,

no or only inefficient man-to-man Tx

Influenza pandemic phase WHO

  • 4. Increased

man-to-man Tx, limited outbreak

  • 5. Significant increase

in man-to-man Tx, extended outbreak

  • 6. Pandemic
slide-13
SLIDE 13

Surveillance target (phase H3)

Detect the first generation of H-H

transmission

Identify risk groups and trace all

contacts

Limit the H-H transmission within 2

generation

Possible dream?? Possible dream??

slide-14
SLIDE 14

Structure

Health facility base reporting system Hotline for case notification Media check

slide-15
SLIDE 15

Health volunteers & community leaders

Initiate and coordinate the network, emergency commander, monitoring and report

Medical care & Network:

Detect, Report, treat

SRRT:

rapid diagnosis, Investigation Control Warning

Medical care & network

Health services

SRRTs

Mr Bird Flu

Surveillance and Control: structure at province

slide-16
SLIDE 16

Case detection and report

slide-17
SLIDE 17

Clinical practice guideline Clinical practice guideline

slide-18
SLIDE 18

Group1

slide-19
SLIDE 19

Group 2

slide-20
SLIDE 20

Group 3

Cluster of ILI (5case in the same community in 1 wk)

  • Confirm diagnosis
  • Active case finding
  • Describe the distribution by time, place, person
  • Control : increase social distance,
slide-21
SLIDE 21

Web base report

slide-22
SLIDE 22

Data management & analysis

slide-23
SLIDE 23

Specimen collection

NP swab NP aspiration Tip of ET tube Pair serum

Prepare

  • PPE and trained personnel
  • Nasopharyngeal swab
  • Viral transport media
  • Sterile tube
  • Ice box with ice pack
  • Vehicle for transportation
slide-24
SLIDE 24

Specimen testing

PCR for influenza A or B PCR for Influenza A H1, H3, H5 Viral isolation Neutralization test

slide-25
SLIDE 25

NP swab, T swab, NP aspirate

RT-PCR

Culture when NPA, or PCR + : Flu A

+

  • Flu A

Flu B H1 RT-PCR H3 RT-PCR H5 Realtime-PCR H 1 or H 3 + H 5 + All neg Real time PCR RT-PCR + + => Report H5 +

  • => wait for isolation/new specimen
  • N/D => Report non-H5

Report

  • 1. Detect CPE and IFA
  • 2. If H5 + repeat PCR

Flow of laboratory confirm

slide-26
SLIDE 26

Lab facilities

Hospitals Regional lab 12 labs PCR for Influenza A and B PCR for Influenza H1 H3 H5 National lab P 3 PCR for Influenza A and B PCR for Influenza H1 H3 H5 Viral isolation Negative Discard Positive for H5 Clinical screening for notification criteria Specimen collection

Screening: Dengue Leptospirosis Melioidosis Bacteria

Report to Hospital and NIH Confirm Positive for H5 Report to Higher policy BOE Hospital

slide-27
SLIDE 27

Case monitoring

Exposure

Direct contact without protection

+++

Living in areas

++

Contact to other pneumonia case

+

Clinical

Severe pneumonia

++++

Pneumonia

+++

ILI admitted

++

ILI not admitted

+

slide-28
SLIDE 28

Case classification

Case under surveillance Suspect case Probable case Confirm case Excluded case

Classification conduct when finish lab process, recover

slide-29
SLIDE 29

Case definitions for surveillance Case definitions for surveillance (15 May 2006)

(15 May 2006)

  • Suspect

Suspect: : An individual whose body temperature is more than 38o C and who has at least one of the following symptoms: muscle pain, cough, breathing difficulty, shortness of breath, or physician suspects pneumonia or influenza, and

who has a history of direct contact with sick or dead poultry in

the last 7 days or

there were reports of unusual poultry deaths in the village in the

last 14 days or

has been looking after another pneumonia patient in the last 10

days before illness onset, but

who does not have a specimen which complies with the

recommendation for laboratory testing for Influenza A/H5

slide-30
SLIDE 30
  • Probable case

Probable case: a suspect who developed signs and symptoms of, or died from, acute respiratory failure

  • Confirmed case

Confirmed case: a suspect who has a final standard laboratory confirmation of Influenza A/H5 through at least

  • ne of the following methods:

Single RT-PCR method using two primer/probe sets,

  • r using specimens collected from at least two different

locations (such as throat swab and nasopharyngeal aspirate, etc.), or using at least two specimens collected from a patient at different period of illness),

Viral culture Neutralization test (four-fold antibody increase

between acute and convalescent serum

Case definitions for surveillance Case definitions for surveillance (15 May 2006)

(15 May 2006)

slide-31
SLIDE 31

Sharing information among epidemiology and lab

Daily lab result updated via e-mail report Daily situation report via e-mail Web base situation report for public:

www.dld.go.th http://epid.moph.go.th

slide-32
SLIDE 32

System evaluation

slide-33
SLIDE 33

Weekly case report with zero report check

Number of reported cases by week 2006

week number

slide-34
SLIDE 34

Geographic distribution

slide-35
SLIDE 35

Lessons learned

Pitfall of case detection Surveillance is working with not only data

BUT PEOPLE

slide-36
SLIDE 36

Pitfall of case detection

Lack of history taking Rely on laboratory

Time at collection Quality of collection process Quality of specimen transportation Media Quality of the test

Miss diagnosis to other diseases

slide-37
SLIDE 37

Quick test result H1, H3, flu B

Sensitivity: 88%, PVP= 72% Specificity: 89% NPV=96%

PCR

Rapid test

positive negative Total Positive

265 100 365

Negative

36 882 918

Total

301 982 1283

BUT

Rapid test for 2 confirm H5, all are negative

slide-38
SLIDE 38

Working with people

Initiate and maintenance Centralize VS De-centralize data Warning VS threatening Simplicity and flexibility Trust and friendship

slide-39
SLIDE 39

Thank you

  • Dr. Kumnuan Ungchusak
  • Dr. Rungnapa Prasarnthong
  • Dr. Supamitr Schunsuthiwat

Surveillance and Response unit, BOE Epidemiologist at provincial health office, Thailand Regional office of diseases control 1-12 Department of Medical Science, NIH Department of Medical Service Department of Livestock, NIAH FETP

slide-40
SLIDE 40

ขอบคุณคะ ขอบคุณคะ Thank you Thank you